Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

Effectively killed multiple human ER+ breast cancer cell lines in culture. Was well tolerated, with no obvious deleterious effects, by multiple species (mice, rats and beagles). Shrank ...

Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

A study by DKFZ researchers shows that inhibiting the enzyme aldolase A in glycolysis traps energy in liver cancer cells, ...

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

Glycolysis is an important sugar degradation pathway that cancer cells in particular depend on. Scientists at the German Cancer Research Center (DKFZ) have now shown that liver cancer cells in mice ...

According to the World Health Organization (WHO), in 2022, there were 2.3 million women diagnosed with breast cancer and 670 ...

Exciting research unveils a single-dose treatment that could potentially change breast cancer therapy by eliminating small tumors and reducing large ones in mice without notable side effects. A ...